These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6260340)

  • 41. Ascending myeloencephalopathy due to intrathecal vincristine sulfate. A fatal chemotherapeutic error.
    Williams ME; Walker AN; Bracikowski JP; Garner L; Wilson KD; Carpenter JT
    Cancer; 1983 Jun; 51(11):2041-7. PubMed ID: 6573227
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The pharmacokinetics of vincristine in man: reduced drug clearance associated with raised serum alkaline phosphatase and dose-limited elimination.
    Van den Berg HW; Desai ZR; Wilson R; Kennedy G; Bridges JM; Shanks RG
    Cancer Chemother Pharmacol; 1982; 8(2):215-9. PubMed ID: 7105384
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cerebrospinal fluid ferritin in patients with leukaemia and malignant lymphoma.
    Milman N; Vig L; Pedersen NS; Olsen TS
    Scand J Haematol; 1985 Aug; 35(2):132-6. PubMed ID: 3863234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of vincristine sulfate in children.
    Sethi VS; Kimball JC
    Cancer Chemother Pharmacol; 1981; 6(2):111-5. PubMed ID: 7307229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Meningeal involvement in acute lymphoblastic leukemia and malignant lymphoma. Value of the assay of beta 2 microglobulin in the cerebrospinal fluid].
    Thyss A; Krebs BP; Caldani C; Borg M; Schneider M
    Presse Med; 1984 Oct; 13(35):2149. PubMed ID: 6238319
    [No Abstract]   [Full Text] [Related]  

  • 46. The pharmacokinetics of [3H]-vincristine in man.
    Bender RA; Castle MC; Margileth DA; Oliverio VT
    Clin Pharmacol Ther; 1977 Oct; 22(4):430-5. PubMed ID: 902455
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Seizures associated with vincristine sulfate therapy.
    Johnson FL; Bernstein ID; Hartmann JR; Chard RL
    J Pediatr; 1973 Apr; 82(4):699-702. PubMed ID: 4512319
    [No Abstract]   [Full Text] [Related]  

  • 48. Kinetics of aluminum in rats. IV: Blood and cerebrospinal fluid kinetics.
    Xu ZC; Tang JP; Xu ZX; Melethil S
    Toxicol Lett; 1992 Oct; 63(1):7-12. PubMed ID: 1412525
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of intraventricular administration.
    Collins JM
    J Neurooncol; 1983; 1(4):283-91. PubMed ID: 6432967
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Can severe vincristine neurotoxicity be prevented?
    Desai ZR; Van den Berg HW; Bridges JM; Shanks RG
    Cancer Chemother Pharmacol; 1982; 8(2):211-4. PubMed ID: 6125275
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Overdosage with vincristine.
    Kaufman IA; Kung FH; Koenig HM; Giammona ST
    J Pediatr; 1976 Oct; 89(4):671-4. PubMed ID: 182948
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differences between vinblastine and vincristine in distribution in the blood of rats and binding by platelets and malignant cells.
    Gout PW; Wijcik LL; Beer CT
    Eur J Cancer (1965); 1978 Nov; 14(11):1167-78. PubMed ID: 738324
    [No Abstract]   [Full Text] [Related]  

  • 53. Local production of reactive oxygen species drives vincristine-induced axon degeneration.
    Gomez-Deza J; Slavutsky AL; Nebiyou M; Le Pichon CE
    Cell Death Dis; 2023 Dec; 14(12):807. PubMed ID: 38065950
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vincristine-based nanoformulations: a preclinical and clinical studies overview.
    Shukla R; Singh A; Singh KK
    Drug Deliv Transl Res; 2024 Jan; 14(1):1-16. PubMed ID: 37552393
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug Resistance in Medulloblastoma Is Driven by YB-1, ABCB1 and a Seven-Gene Drug Signature.
    Taylor L; Wade PK; Johnson JEC; Aldighieri M; Morlando S; Di Leva G; Kerr ID; Coyle B
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831428
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blockade of Cholecystokinin Type 2 Receptors Prevents the Onset of Vincristine-Induced Neuropathy in Mice.
    Bernard A; Danigo A; Mroué M; Rovini A; Richard L; Nizou A; Desmoulière A; Sturtz F; Demiot C; Bourthoumieu S
    Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559317
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differences in P-glycoprotein activity in human and rodent blood-brain barrier assessed by mechanistic modelling.
    Verscheijden LFM; Koenderink JB; de Wildt SN; Russel FGM
    Arch Toxicol; 2021 Sep; 95(9):3015-3029. PubMed ID: 34268580
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current and emerging therapies for primary central nervous system lymphoma.
    Yuan Y; Ding T; Wang S; Chen H; Mao Y; Chen T
    Biomark Res; 2021 May; 9(1):32. PubMed ID: 33957995
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 3D spheroid models of paediatric SHH medulloblastoma mimic tumour biology, drug response and metastatic dissemination.
    Roper SJ; Linke F; Scotting PJ; Coyle B
    Sci Rep; 2021 Feb; 11(1):4259. PubMed ID: 33608621
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A decision process for drug discovery in retinoblastoma.
    Cancela MB; Zugbi S; Winter U; Martinez AL; Sampor C; Sgroi M; Francis JH; Garippa R; Abramson DH; Chantada G; Schaiquevich P
    Invest New Drugs; 2021 Apr; 39(2):426-441. PubMed ID: 33200242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.